Gossamer Bio, Inc. (GOSS)
0.4374
-0.01
(-2.99%)
USD |
NASDAQ |
Apr 16, 16:00
0.44
0.00 (0.00%)
Pre-Market: 09:07
Gossamer Bio Research and Development Expense (Quarterly) : 48.93M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 29.01M |
| Artelo Biosciences, Inc. | 0.893M |
| Arvinas, Inc. | 59.80M |
| Quince Therapeutics, Inc. | 12.60M |
| Vir Biotechnology, Inc. | 85.53M |